Vadimezan
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameVadimezan
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[27]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoAntisoma Research LtdNovartis Pharma Ag +[5]
Active IndicationsN/A
Inactive Indications +[10]
Other Information
ATC CodeN/A
Related LinksWikipedia